Sucofer 100 mg/5 ml (IV Injection or Infusion)

Indications

• Treatment of Sucofer deficiency in various patient groups
• Rapid Sucofer supply in clinical need
• Treatment of Sucofer deficiency anaemia in surgical patients
• Treatment of Sucofer deficiency anaemia in postpartum patients
• Treatment of Sucofer deficiency anaemia in blood donors

Pharmacology

• Therapeutic class: haematinic
• Iron Sucrose Injection USP description
• Approximately 30% Sucrose w/v
• pH of 10.5-11.1
• Dissociation and transfer of Iron and Sucrose in the body
• Iron distribution in the body
• Elimination process of Sucrose

Dosage

• Adult dosage: 5-10 ml Iron Sucrose Injection once to three times a week
• Children dosage: limited data available; caution based on haemoglobin level

Administration

• Intravenous injection method
• Slow intravenous injection rate
• Maximum recommended injection per session
• Test dose recommendation
• Infusion method
• Dilution guidelines for infusion
• Infusion time based on Iron dosage

Interaction

• Lack of studied drug interactions
• Recommendations against concomitant oral iron preparations
• Wait period between oral iron therapy and Sucofer injection

Contraindications

• Contradictions for patients with Iron overload
• Known hypersensitivity to Iron Sucrose or its components
• Anaemia not caused by Iron deficiency
• History of allergic disorders, liver disease, and infections

Side Effects

• Adverse reactions such as hypotension, cramps, nausea, headache, vomiting, and diarrhea
• Various systemic and organ-specific side effects

Pregnancy & Lactation

• Pregnancy Category-B
• Caution in use during pregnancy
• Unknown excretion in human milk

Precautions & Warnings

• Monitoring of hematologic and haematinic parameters
• Caution for hypersensitivity reactions
• Considerations for hypotension

Use in Special Populations

• Safety and effectiveness in pediatric patients not established
• No significant differences observed in elderly subjects
• Specific guidelines for patients with Chronic Kidney Disease

Overdose Effects

• Potential risk of hemosiderosis from excessive dosage
• Symptoms and consequences of overdose
• Monitoring and discontinuation recommendations

Therapeutic Class

• Parenteral Iron Preparations

Storage Conditions

• Cool and dry storage
• Protection from light
• Precaution against freezing

Related Brands

• Anefer 100 mg/5 ml (IV Injection or Infusion) - opsonin-pharma-ltd
• Anofer 100 mg/5 ml (IV Injection or Infusion) - monicopharma-ltd
• Defiron 100 mg/5 ml (IV Injection or Infusion) - square-pharmaceuticals-plc
• Ferimax 100 mg/5 ml (IV Injection or Infusion) - incepta-pharmaceuticals-ltd
• Feristar 100 mg/5 ml (IV Injection or Infusion) - renata-limited